Activity of Caprine CSN1S2 Protein Reducing the COX-2 and IL-17 Expression of Aorta Tissue in Type 2 Diabetes Mellitus Rat
DOI:
https://doi.org/10.5614/j.math.fund.sci.2018.50.3.8Keywords:
aorta, caprine CSN1S2 protein, cyclooxygenase, type 2 diabetes mellitus, inflammationAbstract
Type 2 diabetes mellitus (T2DM) is a degenerative disease that leads to increased inflammation and cyclooxygenase protein production, which causes tissue abnormalities. The aim of this study was to determine the effect of caprine CSN1S2 protein against abnormal metabolic pathways in the aorta of DM rats. The twenty-four-animal model was control, diabetes and treatment groups. Histopathological evaluation of the aortic tissue by hematoxylin eosin staining. The expression of cyclooxygenase and inflammatory cytokine was measured by western blotting. In the DM750 groups, the amount of discontinued-endothelial was significantly more reduced than in the other groups. The amount of macrophages in the DM1500- group decreased more than in the DM and DM375 groups. The amount of foam cells in the DM750 and DM1500 groups decreased more than in the DM group and was close to all control groups. The expressions of COX-2 and IL-17 were effectively reduced and vice versa the expression of IL-10 was increased in DM750 compared with the other groups. Meanwhile, COX-1 expression did not change in all groups. This study indicates that caprine CSN1S2 protein at a dose of 750 mg/kg BW has a significant effect on controlling, protecting, and repairing abnormalities in the aortic tissue of T2DM rats.References
Allahverdian, S., Chehroudi, A.C., McManus, B.M., Abraham, T. & Francis, G.A., Contribution of Intimal Smooth Muscle Cells to Cholesterol Accumulation and Macrophage-Like Cells in Human Atherosclerosis, Circulation, 129(15), pp. 1551-1559, 2014.
Basta, G., Receptor for Advanced Glycation End Products and Atherosclerosis: From Basic Mechanisms to Clinical Implications, Atherosclerosis, 196(1), pp. 9-21, 2008.
Bia, R.R., Virgirinia, R.P., Setiawan, B., Soewondo, A. & Fatchiyah, F., Goat Milk CSN1S2 is Able to Decrease the Severity Scoring, TNF-a, and RAGE Expression in Complete Freund's Adjuvant-induced Rheumatoid Arthritis Model of Rats, Biomarkers and Genomic Medicine, 7(2), pp. 64-71, 2015.
Brueggemann, L.I., Mackie, A.R., Mani, B.K., Cribbs, L.L. & Byron, K.L., Differential Effects of Selective Cyclooxygenase-2 Inhibitors on Vascular Smooth Muscle Ion Channels May Account for Differences in Cardiovascular Risk Profiles, Heart and Lung, 76(5), pp. 1053-1061, 2009
Budiarti, I., Padaga, M. & Fatchiyah, Nutritional Composition and Protein Profile of Goat Yogurt PE with Double Culture between Streptococcus, Cukurova Med J, 38(4), pp. 681-686, 2013.
Chotimah, C., Ciptadi, G., Setiawan, B. & Fatchiyah, F., CSN1S2 Protein of Goat Milk Inhibits the Decrease of Viability and Increases the Proliferation of MC3T3E1 Pre-osteoblast Cell in Methyl Glyoxal Exposure. Asian Pacific Journal of Tropical Disease, 5(3), pp. 219-223, 2015.
Cunha, N.V., de Abreu, S.B. & Panis, C., COX-2 Inhibition Attenuates Cardiovascular and Inflammatory Aspects in Monosodium Glutamate-Induced Obese Rats, Life Sciences, 87(11-12), pp. 375-381, 2010.
Ding, Z., Wang, X. & Schnackenberg, L., Regulation of Autophagy and Apoptosis in Response to Ox-LDL in Vascular Smooth Muscle Cells, and the Modulatory Effects of the MicroRNA hsa-let-7g, International Journal of Cardiology, 168(2), pp. 1378-1385, 2013
Fatchiyah, F., Hardiyanti, F. & Widodo, N., Selective Inhibition on RAGE-binding AGEs Required by Bioactive Peptide Alpha-S2 Casein Protein from Goat Ethawah Breed Milk: Study of Biological Modeling, Acta Informatica Medica, 23(2), pp. 90-96, 2015.
Feletou, M., Huang, Y. & Vanhoutte, P.M., Endothelium-mediated Control of Vascular Tone: COX-1 and COX-2 Products, British Journal of Pharmacology, 164(3), pp. 894-912, 2011.
Galkina, E. & Ley, K., Immune and Inflammatory Mechanisms of Atherosclerosis, Annu Rev Immunol, 27, pp. 165-197, 2009.
Gao, S. Liu, Z. Li, H. Little, P.J. Liu, P. & Xu, S., Cardiovascular Actions and Therapeutic Potential of Tanshinone IIA, Atherosclerosis, 220(1), pp. 3-10, 2012.
Gargiulo, S., Gramanzini, M. & Mancini, M., Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models, International Journal of Molecular Sciences, 17(9), pp. 1-44, 2016.
Hansson, G.K. & Hermansson, A., The Immune System in Atherosclerosis, Nature Immunology, 12(3), pp. 204-212, 2011.
International Diabetes Federation, IDF Diabetes Atlas, 7th edition, 2015.
Karbach, S., Croxford, A.L. & Oelze, M., Interleukin 17 Drives Vascular Inflammation, Endothelial Dysfunction, and Arterial Hypertension in Psoriasis-Like Skin Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, 34(12), pp. 2658-2668, 2014.
Kawahara, K., Hohjoh, H., Inazumi, T., Tsuchiya, S. & Sugimoto, Y., Prostaglandin E2-induced Inflammation: Relevance of Prostaglandin e Receptors, Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1851(4), pp. 414-421, 2015.
Kellogg, A.P., Cheng, H.T. & Pop-Busui, R., Cyclooxygenase-2 Pathway as A Potential Therapeutic Target in Diabetic Peripheral Neuropathy, Current Drug Targets, 9(1), pp. 68-76, 2008.
Klop, B., Elte, J.W.F. & Cabezas, M.C., Dyslipidemia in Obesity: Mechanisms and Potential Targets, Nutrients, 5(4), pp. 1218-1240, 2013.
Luo, W. Liu, B. & Zhou, Y., The Endothelial Cyclooxygenase Pathway: Insights from Mouse Arteries, European Journal of Pharmacology, 780, pp. 148-158, 2016.
Meng, L., Park, J., Cai, Q., Lanting, L. Reddy, M.A. & Natarajan, R., Diabetic Conditions Promote Binding of Monocytes to Vascular Smooth Muscle Cells and their Subsequent Differentiation, American Journal of Physiology - Heart and Circulatory Physiology, 298(3), pp. 736-745, 2010.
Potenza, M., Nacci, C., Gagliardi, S. & Montagnani, M., Cardiovascular Complications in Diabetes: Lessons from Animal Models, Current Medicinal Chemistry, 18(12), pp. 1806-1819, 2011.
Rao, V.S., Srinivas, K., Sujini, G.N. & Kumar, G.N.S., Protein-Protein Interaction Detection: Methods and Analysis, International Journal of Proteomics, pp. 1-12, 2014.
Ray, A., Huisman, M.V. & Tamsma, J.T., The Role of Inflammation on Atherosclerosis, Intermediate and Clinical Cardiovascular Endpoints in Type 2 Diabetes Mellitus, European Journal of Internal Medicine, 20(3), pp. 253-260, 2009.
Ricciotti, E. & Fitzgerald, G.A., Prostaglandins and Inflammation, Arteriosclerosis, Thrombosis, and Vascular Biology, 31(5), pp. 986-1000, 2011.
Rohmah, R.N., Widjajanto, E. & Fatchiyah, F., Protective Effect of CSN1S2 Protein of Goat Milk on Ileum Micro Structure and Inflammation in Rat-CFA-Induced Rheumatoid Arthritis, Asian Pacific Journal of Tropical Disease, 5(7), pp. 564-568 2015.
Rosenfeld, M.E. & Campbell, L.A., Pathogens and Atherosclerosis: Update on the Potential Contribution of Multiple Infectious Organisms to the Pathogenesis of Atherosclerosis, Thrombosis and Haemostasis, 106(5), pp. 858-867, 2011.
Sanz, J. & Fayad, Z., Imaging of Atherosclerotic Cardiovascular Disease, Nature, 451(7181), pp. 953-957, 2008.
Taleb, S., Tedgui, A. & Mallat, Z., IL-17 and Th17 Cells in Atherosclerosis: Subtle and Contextual Roles, Arteriosclerosis, Thrombosis, and Vascular Biology, 35(2), pp. 258-264, 2015.
Tang, S.Y., Monslow, J., Todd, L., Lawson, J., Pure, E. & Fitzgerald, G.A., Cyclooxygenase-2 in Endothelial and Vascular Smooth Muscle Cells Restraints Atherogenesis in Hyperlipidemic Mice, Circulation, 129(17), pp. 1761-1769, 2014.
Taube, A., Schlich, R., Sell, H., Eckardt, K. & Eckel, J., Inflammation and Metabolic Dysfunction: Links to Cardiovascular Diseases, American Journal of Physiology Heart and Circulatory Physiology, 302(11), pp. 2148-2165, 2012.
Triggle, C.R., Samuel, S.M., Ravishankar, S., Marei, I., Arunachalam. G. & Ding. H., The Endothelium: Influencing Vascular Smooth Muscle in Many Ways, Canadian Journal of Physiology and Pharmacology, 90(6), pp. 713-738, 2012.
Waqar, A.B. Koike, T. & Yu, Y., High-fat Diet without Excess Calories Induces Metabolic Disorders and Enhances Atherosclerosis in Rabbits, Atherosclerosis, 213(1), pp 148-155, 2010.
Yar, A.S., Menevse, S., Alp. E., Helvacioglu, F. & Take, G., The Effects of Resveratrol on Cyclooxygenase-1 and Cyclooxygenase-2 mRNA and Protein Levels in Diabetic Rat Kidneys, Molecular Biology Reports, 37(5), pp. 2323-2331, 2010.
